Amneal Pharmaceuticals

Amneal Pharmaceuticals is a global biopharmaceutical company that develops and manufactures complex generics, biosciences and specialty medicines. Founded in 2002, the company has operated for more than two decades and manufactures a portfolio of more than 290 pharmaceutical products. Its stated purpose is to make essential medicines accessible to people regardless of their ability to pay, with work addressing public-health priorities such as drug shortages and affordable cancer treatment.

The company's product lines span three areas. Biosimilars are developed as lower-cost medicines to fight cancer. Injectable medicines are aimed at persistent shortages of sterile drugs. A broader portfolio of complex generics and specialty medicines rounds out the offering. Technical work sits in areas including biosimilars, generic pharmaceuticals, specialty medicines, injectable drug manufacturing, pharmaceutical manufacturing and biologics, alongside industry contexts ranging from generics and oncology to specialty care.

Amneal is headquartered in Bridgewater, New Jersey, and has a presence in the United States, India and Ireland. The company is founder-led by brothers Chirag and Chintu Patel, whose approach draws on values of honesty and integrity attributed to their father, Kanu Patel, an industrial pharmacist. Its stated mission is to reimagine what is possible to make healthcare accessible for all.